Personalis sues Foresight Dx for patent infringement August 3, 2022 -- Cancer genomics firm Personalis on Tuesday announced that it has filed a lawsuit against Foresight Diagnostics for infringement of patents related to whole genome-enabled, tumor-informed molecular residual disease (MRD) testing.Read More
Video from AACC: PerkinElmer on diagnostics, acquisitions August 2, 2022 -- Greg Stock, general manager of PerkinElmer’s Euroimmun business, discussed products and technologies on display at AACC 2022, as well as the integration of acquired companies such as Oxford Immunotec.Read More
Video from AACC: First impressions, Day 1 August 2, 2022 -- Reflecting on highlights from the LabPulse.com and ScienceBoard.net team for Day 1, Kalorama Information's Bruce Carlson compares AACC 2022 with previous meetings.Read More
Guardant Health nabs coverage for liquid biopsy MRD test August 2, 2022 -- Guardant Health on Tuesday announced that Palmetto GBA, a Medicare administrative contractor, will provide coverage for the Guardant Reveal liquid biopsy test to detect molecular residual disease (MRD).Read More
Medline signs on as Visby distributor August 2, 2022 -- Medline has signed an agreement with Visby Health to distribute Visby’s instrument-free, point-of-care Sexual Health Click Test.Read More
LucidDx Labs inks four provider deals August 2, 2022 -- Lucid Diagnostics’ LucidDx Labs has inked participating provider agreements with three preferred provider organizations (PPOs) and a specialized diagnostic laboratory network.Read More
PerkinElmer Q2 revenues flat year over year August 2, 2022 -- PerkinElmer on Monday reported second quarter revenues of $1.23 billion, flat year-over-year but surpassing Wall Street analysts’ average estimate of $1.20 billion.Read More
Video from AACC: AACC president on Theranos, VALID Act August 1, 2022 -- Dr. Stephen Master, president of the American Association for Clinical Chemistry, provided his thoughts about the main highlights of the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo held this week in Chicago.Read More